Dermal inflammation in primates, mice, and guinea pigs: Attenuation by second-generation leukotriene B4 receptor antagonist, SC-53228 (original) (raw)

References

  1. Camp, R. D. R., andM. S. Greaves. 1987. Inflammation mediators in the skin.Br. Med. Bull. 43:401–414.
    PubMed Google Scholar
  2. Ziboh, V. A., L. T. Casebolt, C. L. Marcelo, andJ. J. Voorhees. 1984. Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.J. Invest. Dermatol. 83:426–430.
    PubMed Google Scholar
  3. Camp, R. D. R., andF. M. Cunningham. 1988. The role of eicosanoids in inflammatory disorders of the skin.In Advances in Eicosanoid Research: Inflammatory Conditions of the Lung, Skin and Joint. M. Church and C. Robinson, editors. MTP Press, Lancaster. 112.
    Google Scholar
  4. Palmblad, J., C. Malmsten, A. Uden, O. Radmark, L. Engstrot, andB. Samuelson. 1981. Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence.Blood 58:658–661.
    PubMed Google Scholar
  5. Redl, H., P. Flynn, H. Lamche, A. Scheisser, G. Schlag, andD. Hammerschmide. 1983. Aggregation, chemotaxis and chemiluminescence of canine granulocytes.Inflammation 7:67–79.
    PubMed Google Scholar
  6. Ford-Hutchinson, A. W., M. Bray, M. Doig, M. Shipley, andM. Smith. 1980. Leukotriene B4, a potent chemokinetic and aggregation subtance release from polymorphonuclear leukocytes.Nature 286:254–265.
    Google Scholar
  7. Hoover, R., M. Karnovsky, K. F. Austen, E. J. Corey, andR. Lewis. 1984. Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion.Proc. Natl. Acad. Sci. U.S.A. 81:2191–2193.
    PubMed Google Scholar
  8. Reusch, M. K., S. H. Fullerton, B. J. Nikoloff, W. Glinski, andM. A. Karasek. 1988. Leukotriene B4 enhances adherence of human polymorphonuclear leukocytes to dermal microvascular endothelial cells in vitro.Arch. Dermatol. Res. 280:194–197.
    PubMed Google Scholar
  9. Czarnetski, B., andR. Mertensmeir. 1985. In vitro and in vivo chemotaxis of guinea pig leukocytes toward leukotriene B4 and its ω-oxidation products.Prostaglandins 30:5–11.
    PubMed Google Scholar
  10. Colditz, I., andH. J. Movat. 1984. Kinetics of neutrophil accumulation in acute inflammatory lesions induces by chemotaxis and chemotaxinigens.J. Immunol. 133:2169–2173.
    PubMed Google Scholar
  11. Bhattacherjee, P., B. Hammond, J. Salmon, R. Stepney, andK. Eakins. 1981. Chemotactic response to some arachidonic acid lipoxygenase products in the rabbit eye.Eur. J. Pharmacol. 73:21–28.
    PubMed Google Scholar
  12. Erlansson, M., E. Svensjo, andD. Bergquist. 1989. Leukotriene B4-induced permeability increased in postcapillary venules and its inhibition by three different antiinflammatory drugs.Inflammation 13:693–705.
    PubMed Google Scholar
  13. Camp, R. D. R., A. Coutts, M. W. Greaves, A. Kay, andM. Walport. 1983. Responses of human skin to intradermal injection of leukotrienes C4, D4, and B4.Br. J. Pharmacol. 8:497–502.
    Google Scholar
  14. Soter, N., R. Lewis, E. J. Corey, andK. F. Austen. 1983. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin.J. Invest. Dermatol. 80:115–119.
    PubMed Google Scholar
  15. Kecskes, A., andJ. Levy. 1994. Non-invasive characterization of LTB4 reaction on healthy human skin.Arch. Pharmacol. 349(Suppl):R139.
    Google Scholar
  16. De Jong, E., P. Van Erp, I. Van Vlijmen, P. Hedley-Jones, andP. Van De Kerkhof. 1992. The inter-relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene B4.Clin. Exp. Dermatol. 17:413–420.
    PubMed Google Scholar
  17. Iwamoto, I., S. Tomoe, H. Tomioka, andS. Yoshida. 1993. Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin.J. Immunol. 151:2116–2123.
    PubMed Google Scholar
  18. Griffiths, R. J., B. E. Woods, S. Li, andA. Blackham. 1988. Pharmacological modification of 12-_O_-tetradecanoyl-phorbol-13-acetate induced inflammation and epidermal cell proliferation in mouse skin.Agents Actions 25:344–351.
    PubMed Google Scholar
  19. De Young, L. M., J. B. Kheifets, S. J. Ballaron, andJ. M. Young. 1989. Edema and cell infiltration in the phorbol ester-treated mouse can be differentially modulated by pharmacologic agents.Agents Actions 26:335–341.
    PubMed Google Scholar
  20. Bourin, M. C., C. Delescluse, G. Furstenberger, F. Marks, J. Schweizer, A. Klein-Szanto, andM. Prunieras. 1982. Effect of phorbol esters on guinea pig skin in vivo.Carcinogenesis 3:671–676.
    PubMed Google Scholar
  21. Sprague, R., A. Stephenson, T. Dahms, andA. Lonigro. 1990. Production of leukotrienes in phorbol ester-induced acute lung injury.Prostaglandins 39:439–450.
    PubMed Google Scholar
  22. Krawisz, J., P. Sharon, andW. Stenson. 1984. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity.Gastroenterology 87:1344–1350.
    PubMed Google Scholar
  23. Gillespie, M., S. Goldblum, D. Cohen, andC. McClain. 1988. Interleukin-1 bioactivity in lungs of rats.Proc. Soc. Exp. Biol. Med. 187:26–32.
    PubMed Google Scholar
  24. Bradley, P., D. Priebat, R. Christensen, andG. Rothstein. 1982. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker.J. Invest. Dermatol. 78:206–209.
    PubMed Google Scholar
  25. Djuric, S., S. Docter, S. Yu.,B. Tsai, C. Anglin, T. Gaginella, J. Kachur, T. Maziasz, D. Price, T. Rao, R. Walsh, D. Widomski, andD. Fretland. 1994. Synthesis and pharmacological activity of SC-53228.Biol. Med. Chem. Lett. 4:811–816.
    Google Scholar
  26. Tsai, B., R. Keith, D. Villani-Price, J. Kachur, D. Yang, S. Djuric, andS. Yu. 1994. The in vitro pharamcology of SC-51146: A potent antagonist of leukotriene B4 receptors.J. Pharmacol. Exp. Ther. 268:1499–1505.
    PubMed Google Scholar
  27. Shone, T., S. Djuric, B. Tsai, D. Fretland, T. Gaginella, andC. Cook. 1990. SC-41930.Drugs Future 15:695–697.
    Google Scholar
  28. Boughton-Smith, N., J. Wallace, andB. Whittle. 1988. Relationships between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease.Agents Actions 25:115–123.
    PubMed Google Scholar
  29. Penning, T., S. Djuric, S. Docter, S. Yu, D. Fretland, B. Tsai, andD. Widomski. 1993. The design and synthesis of second generation LTB4 receptor antagonists related to SC-41930.Agents Actions 39:C11-C13.
    PubMed Google Scholar
  30. Fretland, D., D. Widomski, J. Zemaitis, R. Walsh, S. Levin, S. Djuric, R. Shone, B. Tsai, andT. Gaginella. 1990. Inflammation of the guinea pig dermis: effects of the LTB4 receptor antagonist, SC-41930.Inflammation 14:727–739.
    PubMed Google Scholar
  31. Sundberg, J., D. Boggess, B. Sundberg, W. Beamer, andL. Shultz. 1993. Epidermal dendritic cell populations in the flaky skin mutant mouse.Immunol. Invest. 22:389–401.
    PubMed Google Scholar
  32. Sundberg, J. P., G. Kenty, W. G. Beamer, A. C. Ventura, andD. L. Adkinson. 1992. Forestomach papillomas in flaky skin and steel-Dickie mutant mice.J. Vet. Diagn. Invest. 4:312–317.
    PubMed Google Scholar
  33. Rao, T., J. Currie, A. Shaffer, andP. Isakson. 1993. Comparative evaluation of arachidonic acid and tetradecanoylphorbol acetate-induced dermal inflammation.Inflammation 17:723–741.
    PubMed Google Scholar
  34. Brain, S., R. Camp, P. Dowd, A. Kobza-Black, andM. Greaves. 1984. The release of leukotriene-B4-like material in biologically active amounts from the lesional skin of patients with psoriasis.J. Invest. Dermatol. 83:70–73.
    PubMed Google Scholar
  35. Ford-Hutchinson, A. W. 1993. 5-Lipoxygenase activation in psoriasis: A dead issue?Skin Pharmacol. 6:292–297.
    PubMed Google Scholar
  36. Fretland, D. J., andS. W. Djuric. 1989. 12(R)- and 12(S)-Hydroxyeicosatetraenoic acids: Chemistry, biology and pharmacology.Prostaglandins Leukotrienes Essent. Fatty Acids 38:215–228.
    Google Scholar
  37. Barr, R., S. Brain, R. D. R. Camp, F. F. Derm, J. Cilliers, M. W. Greaves, A. Mauet, andK. Misch. 1984. Levels of arachidonic acid metabolites in the skin in human allergic and irritant contact dermatitis.Er. J. Dermatol. 111:23–28.
    Google Scholar
  38. Ruzicka, T., T. Simmet, andB. A. Peskar. 1986. Skin levels of arachidonic acid-derived inflammation mediators and histamine in atopic dermatitis and psoriasis.J. Invest. Dermatol. 86:105–108.
    PubMed Google Scholar
  39. Fretland, D., C. Anglin, M. Bremer, P. Isakson, D. Widomski, S. Paulson, S. Docter, S. Djuric, T. Penning, S. Yu, andJ. P. McKearn. 1995. Antiinflammatory effects of the second generation leukotriene B4 receptor antagonist, SC-53228.Inflammation 19:193–205.
    PubMed Google Scholar
  40. Gross, E., andT. Ruzicka. 1992. Epidermal eicosanoid receptors.In Pharmacology of the Skin. H. Mukhtar, editor. CRC Press, Boca Raton. 331.
    Google Scholar
  41. Nagao, S., M. Seishima, S. Mori, andY. Nozawa. 1988. Increased protein kinase C activity in fibroblast membranes from psoriatic patients.J. Invest. Dermatol. 90:406–408.
    PubMed Google Scholar
  42. Gupta, A., G. Fisher, J. Elder, B. Nickoloff, andJ. Voorhees. 1988. Sphingosine inhibits phorbol ester-induced inflammation, ornithine decarboxylase activity and activation of protein kinase C in mouse skin.J. Invest. Dermatol. 91:486–491.
    PubMed Google Scholar
  43. McColl, S. R., N. P. Hurst, W. H. Betts, andL. G. Cleland. 1987. Modulation of human neutrophil LTA4 hydrolase activity by phorbol myristate acetate.Biochem. Biophys. Res. Commun. 142:622–626.
    Google Scholar
  44. Kobza-Black, A., R. D. R. Camp, F. M. Cunningham, A. Mallet, M. Hofbauer, andM. W. Greaves. 1988. The clinical and pharmacology effect of lonapalene (RS-43179), a 5-lipoxygenase inhibitor, applied topically in psoriasis.Br. J. Dermatol. 119(Suppl. 33):33.
    PubMed Google Scholar
  45. Kobza-Black, A., F. M. Cunningham, A. Mallet, andM. W. Greaves. 1988. Pharmacological effects of lonapalene in psoriasis.J. Invest. Dermatol. 90:550.
    Google Scholar
  46. Koo, J. 1993. SCH-40120: A novel leukotriene and cytokine inhibitor in the treatment of human psoriasis.J. Invest. Dermatol. 101:A502.
    Google Scholar
  47. Barr, R. M., A. Kobza-Black, P. M. Dowd, O. Koro, K. Mistry, J. L. Issacs, andM. W. Greaves. 1988. The in vitro 5-lipoxygenase and cyclooxygenase inhibitor L-652,343 does not inhibit 5-lipoxygenase in vivo in human skin.Br. J. Clin. Pharmacol. 25:23–26.
    PubMed Google Scholar
  48. De Jong, E., E. van Vligmen, J. Scholte, A. Buntinx, B. Friedman, W. Tanaka, andP. Van De Kerkhof. 1991. Clinical and biochemical effects of an oral leukotriene biosynthesis inhibitor, MK886, in psoriasis.Skin Pharmacol. 4:278–285.
    PubMed Google Scholar
  49. Von Zepelin, H. H., U. Mroweitz, L. Farber, K. Brick-Borchers, C. Schober, J. Huber, G. Lutz, R. Kohnen, C. Christophers, andD. Welzel. 1993. Highly purified omega-3-polyunsaturated fatty acids in treatment of psoriasis.Br. J. Dermatol. 129:713–717.
    PubMed Google Scholar
  50. Soyland, E., J. Funk, G. Rajka, M. Sandberg, H. Wadstrom, L. Rustad, andS. Helland. 1994. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis.Br. J. Dermatol. 130:757–764.
    PubMed Google Scholar
  51. Greaves, M. W., andR. D. R. Camp. 1988. Prostaglandins, leukotrienes, phospholipase, platelet activating factor and cytokines: An integrated approach to inflammation of human skin.Arch. Dermatol. Res. 280(Suppl.):S33-S41.
    PubMed Google Scholar
  52. Bull, H. A., andP. M. Dowd. 1992. Prostaglandin synthetase, interleukin 1 and inflammation in the skin.Prostaglandins Leukotrienes Essent. Fatty Acids 46:167–173.
    Google Scholar
  53. Ziboh, V. A. 1994. Essential fatty acids and eicosanoid biosynthesis in the skin: biological significance.Proc. Soc. Exp. Biol. Med. 205:1–11.
    PubMed Google Scholar
  54. Djuric, S. W., D. J. Fretland, andT. D. Penning. 1992. The leukotriene B4 receptor antagonists—a most discriminating class of antiinflammatory agents?Drugs Future 17:819–830.
    Google Scholar

Download references